The HemOnc Pulse Live at ASH: Robert Orlowski, MD, PhD, on Bispecifics, MRD in Myeloma
The HemOnc Pulse Live at ASH: Jennifer R. Brown, MD, PhD, on the ALPINE Study, MRD in CLLПодробнее
The HemOnc Pulse Live at ASH: John DiPersio, MD, PhD, on Challenges, Role of HSCT in AMLПодробнее
Building Real-World Bridges Between Clinicians and Patients With MyelomaПодробнее
Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD, PhD MD Anderson Cancer CenterПодробнее
mPatient Myeloma Radio: Dr. Robert Orlowski, MD, PhD, MD AndersonПодробнее
The 2024 Myeloma Landscape with Robert Orlowski, MD, PhD, MD AndersonПодробнее
The HemOnc Pulse Live at ASH: Thomas Martin, MD, on Frontline Advances, Novel Agents in MyelomaПодробнее
The HemOnc Pulse Live at ASH: Sagar Lonial, MD, FACP, on Role of Transplant, MRD in MyelomaПодробнее
Meet multiple myeloma specialist Robert Orlowski, M.D., Ph.D.Подробнее
Questioning Paradigms - Robert Orlowski, MD, PhD | MCRT Houston, Texas March 26, 2022Подробнее
Precursor Conditions - Robert Orlowski, MD, PhD | MCRT Houston, Texas March 26, 2022Подробнее
Myeloma Crowd Radio: Dr. Robert Z. Orlowski, MD, PhD, MD Anderson Cancer CenterПодробнее
Dr McCarthy on Neutrophil Activity in Multiple MyelomaПодробнее
Myeloma Crowd Radio: Dr. Robert Orlowski, MD, PhD, MD Anderson Cancer CenterПодробнее
How Do You Find Out About Clinical Trials?Подробнее
Myeloma Crowd Radio: Robert Orlowski, MD, PhD, MD Anderson Cancer CenterПодробнее
Myeloma Crowd Radio: Robert Z. Orlowski, MD, PhD, MD Anderson Cancer CenterПодробнее
Dr. Robert Z Orlowski on the Importance of the Phase III SWOG S0777 TrialПодробнее
The HemOnc Pulse Live at ASH: Phillip Scheinberg, MD, on CHIP, MDS Classification UpdatesПодробнее
